Opinion 26 Apr 2023Can mRNA vaccines tackle multiple diseases? By Dr. Myriam Mendila, chief development officer of CureVac World Immunization Week is April 24-30, and it’s an important week… April 26, 2023 - 9 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
In Depth 4 Jul 2022The COVID-19 pandemic has driven RNA therapeutics into the mainstream As messenger RNA vaccines save lives around the world, and RNA interference drugs are greenlit for rare diseases, the field… July 4, 2022 - 8 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 15 Feb 2022Next-Gen Covid-19 Vaccines and Drugs Crowd into Late-Stage Trials Despite the widespread rollout of vaccines over 2021, the Covid-19 pandemic remains a threat to healthcare systems worldwide. Numerous treatments… February 15, 2022 - 7 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Best in Biotech 20 Dec 2021The Billion-Euro European Biotech Companies in 2022 Here’s a list of the public European biotech companies that are worth more than a billion euros in 2022. European… December 20, 2021 - 12 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
Best in Biotech 11 Jan 2021The 21 European Biotech Companies To Watch in 2021 As we enter 2021, the biotech industry is already bustling with activity. Here’s a list of 21 European biotech companies… January 11, 2021 - 11 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
Best in Biotech 28 Dec 2020A Year to Remember: The Biggest European Biotech News in 2020 The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled through. Let’s look back at… December 28, 2020 - 12 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 17 Aug 2020CureVac Continues Covid-19 Vaccine Funding Frenzy with €180M IPO The share price of CureVac has skyrocketed almost fivefold after the Covid-19 vaccine developer priced a Nasdaq IPO at €180M… August 17, 2020 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 23 Jul 2020Pharma Giant GSK and mRNA Biotech CureVac Ink €1B Deal GlaxoSmithKline (GSK) has struck a deal worth up to €1B with the German biotechnology company CureVac to co-develop messenger RNA… July 23, 2020 - 3 minutesmins - By David Wilson Share WhatsApp Twitter Linkedin Email
News and Trends 17 Jun 2020German Government Invests €300M in mRNA Biotech CureVac The Federal Republic of Germany will invest €300M in CureVac, the homegrown biotech that is developing a vaccine for Covid-19… June 17, 2020 - 4 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 29 Apr 2020Update: BioNTech and Pfizer’s mRNA Vaccine for Covid-19 Tested in Humans Update (29/04/2020): A vaccine developed by the German company BioNTech and its big pharma partner Pfizer has become the first… April 29, 2020 - 5 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
In Depth 30 Mar 2020Could mRNA Vaccines Fulfill Their Potential Against Coronavirus? The first vaccine against coronavirus disease could one day be made of mRNA. How is mRNA showing promise against the… March 30, 2020 - 7 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 17 Mar 2020CureVac Receives €80M from EU to Fund Coronavirus Vaccine Amid US Dispute The German biotech CureVac -- which is developing an mRNA vaccine against coronavirus -- has been granted up to €80M… March 17, 2020 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 3 Feb 2020CureVac Bids to Develop First mRNA Coronavirus Vaccine RNA vaccine developer CureVac will receive a grant of up to €8.3M from a global partnership to develop an mRNA… February 3, 2020 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 1 Mar 2019Rapid Response mRNA Vaccine Facility Gets €30M Funding An mRNA vaccine facility, run by the German biotech CureVac, has received a €30M development grant to rapidly manufacture vaccines… March 1, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 11 Dec 2018What Does the Largest Biotech IPO Ever Mean for European Biotech? With a massive €530M ($604M) raised, US-based Moderna has made a record biotech IPO. The news could give a significant… December 11, 2018 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Best in Biotech 20 Feb 2018Money, Money, Money! Europe’s Best-Funded Biotechs in 2018 Besides struggling with ambitious New Year’s resolutions and post-holiday diets, January is a time where many of us re-examine our… February 20, 2018 - 11 minutesmins - By Karen O’Hanlon Cohrt Share WhatsApp Twitter Linkedin Email
Best in Biotech 28 Dec 2017Bored Between the Holidays? Watch these Biotech Videos! Christmas might have passed, but we have more videos for you to watch on a dreary winter day! Here are… December 28, 2017 - 4 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
Best in Biotech 12 Dec 2017Grab the Tissues: Here are the 8 Biggest European Biotech Clinical Failures of 2017 As 2016 was a tough year for biotech, 2017 was under pressure to turn things around. Although there has been… December 12, 2017 - 7 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
Interview 6 Nov 2017Battle of the Biotech Unicorns: CureVac vs. Moderna An interview never seen before. We brought together the founders and CEOs of the two biotech unicorns pioneering mRNA therapy:… November 6, 2017 - 4 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 18 Oct 2017Eli Lilly Offers German Biotech up to €1.5Bn to Develop mRNA Cancer Vaccines CureVac will be working with pharma giant Eli Lilly in the development of up to five cancer vaccines based on… October 18, 2017 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email